Improvement of MBD Parameters in Dialysis Patients by a Switch to, and Combined Use of Lanthanum Carbonate: Josai Dialysis Forum Collaborative Study

The effects of lanthanum carbonate on MBD parameters were investigated in 59 hemodialysis patients who were taking calcium carbonate. Lanthanum carbonate (initial dosage: 750 mg/day), as a replacement for or in combination with calcium carbonate and/or sevelamer hydrochloride, was administered for 1...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Therapeutic apheresis and dialysis 2013-04, Vol.17 (S1), p.29-34
Hauptverfasser:	Shinoda, Toshio, Yamasaki, Masahiro, Chida, Yoshiko, Takagi, Masao, Tanaka, Yoshiko, Ando, Ryoichi, Suzuki, Toshiaki, Tagawa, Hitoshi
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration compliance Bone Diseases - drug therapy Bone Diseases - etiology Calcium - blood Calcium Carbonate - administration & dosage Calcium Carbonate - therapeutic use Dose-Response Relationship, Drug Drug Therapy, Combination Female Follow-Up Studies Hemodialysis patients Humans Hypercalcemia Hyperphosphatemia Lanthanum - administration & dosage Lanthanum - therapeutic use Lanthanum carbonate Male Middle Aged Mineral and bone disorder Parathyroid Hormone - blood Phosphorus - blood Polyamines - administration & dosage Polyamines - therapeutic use Renal Dialysis - methods Sevelamer Vitamin D - administration & dosage Vitamin D - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!